Loss of NOS1 expression in high-grade renal cell carcinoma associated with a shift of NO signalling.
In normal human kidney, NOS1 and soluble guanylate cyclase (sGC) are expressed in tubular epithelial cells, suggesting a physiological autocrine NO signalling pathway. Therefore, we investigated both NOS1 and sGC expressions in benign and malignant renal tumours. In addition, we examined the pattern of protein tyrosine nitration in normal and tumour tissue. NOS1 expression and activity were found to be downregulated, correlating with the tumour grade, as shown by immunohistochemistry, quantitative RT-PCR analysis, and histochemical detection of the NADPH-diaphorase activity of nitric oxide synthases (NOS). These results show that the autocrine NO signalling pathway is maintained in benign tumours and lost in malignant tumours. In contrast, sGC expression was maintained in renal tumours whatever the tumour type, a finding showing that tumour cells remain sensitive to the bioregulatory role of exogeneous NO(*). Finally, the staining pattern of protein tyrosine nitration, assessed by immunohistochemistry, parallelled that of NOS1 expression in normal renal parenchyma and benign tumours, supporting the concept that protein nitration was accounted for by NOS1 activity. In contrast, in malignant tumours, protein tyrosine nitration was accounted for by the production of reactive nitrogen oxide species by the inflammatory infiltrate. Altogether, these findings argue for a pattern of NO signalling similar in normal kidney and benign renal tumours, whereas it is completely different in malignant renal tumours.
Renaudin
K
K
Pathology Department, CHU Hôtel Dieu, 30 Boulevard Jean Monnet, 44093 Nantes Cedex 1, France.
Denis
M G
MG
Karam
G
G
Vallette
G
G
Buzelin
F
F
Laboisse
C L
CL
Jarry
A
A
D002292:Carcinoma, Renal Cell / Q000235:genetics* / Q000473:pathology*; D015536:Down-Regulation; D006162:Guanylate Cyclase / Q000096:biosynthesis*; D006801:Humans; D007150:Immunohistochemistry; D007249:Inflammation; D007680:Kidney Neoplasms / Q000235:genetics* / Q000473:pathology*; D009367:Neoplasm Staging; D009569:Nitric Oxide / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000096:biosynthesis*; D052248:Nitric Oxide Synthase Type I; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction
D009569:Nitric Oxide; C496320:NOS1 protein, human; D019001:Nitric Oxide Synthase; D052248:Nitric Oxide Synthase Type I; D006162:Guanylate Cyclase